Asters advises EBRD on EUR 25 million financing to Yuria-Pharm
Asters acts as a legal counsel to the European Bank for Reconstruction and Development (EBRD) in connection with its EUR 25 million financing to Yuria-Pharm, Ukraine’s leading manufacturer of intensive care medicines, medical devices and antiseptics.
A six-year loan of up to EUR 25 million from the EBRD will help Yuria-Pharm expand its existing production facilities and introduce an innovative solution for the Ukrainian market, which will help customise cancer treatment practices. Healthcare establishments and patients across Ukraine will be able to buy smaller and cheaper doses of specialised medicines.
Asters’ banking and finance team advising on the project consisted of partner Iryna Pokanay, counsel Gabriel Aslanian and associates Inna Bondarenko and Viktoria Zagreba.
The European Bank for Reconstruction and Development (EBRD) is the largest international financial investor in Ukraine. Since the start of its operations in the country in 1993, the Bank has made a cumulative commitment of more than €15 billion through 466 projects in Ukraine.
Asters is the largest law firm in Ukraine with offices in Kyiv, Washington D.C., Brussels and London. Chambers Europe 2020 recognizes 21 lawyers of Asters – the largest number of the renowned practitioners in a single Ukrainian law firm.